US pharma major Eli Lilly plans to bolster its domestic medicine production across therapeutic areas by building four new ...

French biotech start-up studio Argobio and non-profit biomedical research center the Institut Pasteur have announced the ...

The US Food and Drug Administration (FDA) has accepted for review Regeneron Pharmaceuticals’ resubmission of the Biologics ...

Positive high-level results from a planned interim analysis of the SERENA-6 Phase III trial showed that AstraZeneca’s ...

Ligand Pharmaceuticals (Nasdaq: LGND) has entered into a royalty financing agreement with Castle Creek Biosciences, providing ...

Danish dermatology specialist LEO Pharma has announced results showing a strong performance in 2024, with both sales growth ...

Swiss biotech company Idorsia has revised its collaboration terms with Viatris, reducing its financial commitment to the ...

Cardiovascular diseases specialist Kiniksa Pharmaceuticals International has announced updates to its pipeline alongside ...

Chicago, USA-based Emalex Biosciences announced positive top-line data from its Phase III registrational study of ecopipam, a ...

Shares of Sweden’s immune-oncology firm Alligator Bioscience were up almost 160% at 0.11 kronor by early afternoon today, ...

Neurodevelopmental disorders company GRIN Therapeutics, an affiliate of the Blackstone Life Sciences portfolio company ...

Repare Therapeutics is set to cut approximately 75% of its workforce as part of a restructuring plan aimed at extending its ...